rs555388438
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PM5PP3_ModeratePP5
The ENST00000352480.10(ASS1):c.1004G>A(p.Arg335His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,613,408 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R335C) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000352480.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASS1 | NM_054012.4 | c.1004G>A | p.Arg335His | missense_variant | 13/15 | ENST00000352480.10 | NP_446464.1 | |
ASS1 | NM_000050.4 | c.1004G>A | p.Arg335His | missense_variant | 14/16 | NP_000041.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASS1 | ENST00000352480.10 | c.1004G>A | p.Arg335His | missense_variant | 13/15 | 1 | NM_054012.4 | ENSP00000253004 | P1 | |
ASS1 | ENST00000372393.7 | c.1004G>A | p.Arg335His | missense_variant | 14/16 | 5 | ENSP00000361469 | P1 | ||
ASS1 | ENST00000372394.5 | c.1004G>A | p.Arg335His | missense_variant | 14/16 | 2 | ENSP00000361471 | P1 | ||
ASS1 | ENST00000372386.6 | n.275G>A | non_coding_transcript_exon_variant | 4/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 251166Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135774
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461116Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 726872
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74464
ClinVar
Submissions by phenotype
Citrullinemia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 335 of the ASS1 protein (p.Arg335His). This variant is present in population databases (rs555388438, gnomAD 0.01%). This missense change has been observed in individual(s) with citrullinemia and/or elevated citrulline (PMID: 28111830, 31737040; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 555009). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ASS1 protein function with a negative predictive value of 80%. This variant disrupts the p.Arg335 amino acid residue in ASS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Citrullinemia type I Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Nov 10, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at